Publicaciones en las que colabora con MARÍA DE LA PALOMA BALLESTEROS PAPANTONAKIS (17)

2023

  1. Application of Accelerated Predictive Stability Studies in Extemporaneously Compounded Formulations of Chlorhexidine to Assess the Shelf Life

    Molecules, Vol. 28, Núm. 23

  2. Guiding Clinical Prescription of Topical Extemporaneous Formulations of Sodium Cromoglycate Based on Pharmaceutical Performance

    Pharmaceutics, Vol. 15, Núm. 6

  3. Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers

    International journal of pharmaceutics, Vol. 635, pp. 122788

2022

  1. Drug Stability: ICH versus Accelerated Predictive Stability Studies

    Pharmaceutics, Vol. 14, Núm. 11

2017

  1. Engineering oral and parenteral amorphous amphotericin B formulations against experimental Trypanosoma cruzi infections

    Molecular Pharmaceutics, Vol. 14, Núm. 4, pp. 1095-1106

  2. Nebulised antibiotherapy: Conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?

    Annals of Translational Medicine, Vol. 5, Núm. 22

2015

  1. A novel performing PEG-cholane nanoformulation for Amphotericin B delivery

    International Journal of Pharmaceutics, Vol. 495, Núm. 1, pp. 41-51

  2. Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles

    Molecular Pharmaceutics, Vol. 12, Núm. 2, pp. 420-431

2013

  1. Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations

    International Journal of Pharmaceutics, Vol. 447, Núm. 1-2, pp. 38-46

2012

  1. A novel formulation of solubilised amphotericin B designed for ophthalmic use

    International Journal of Pharmaceutics, Vol. 437, Núm. 1-2, pp. 80-82

2008

  1. Amphotericin B formulations and drug targeting

    Journal of Pharmaceutical Sciences, Vol. 97, Núm. 7, pp. 2405-2425

  2. Effect of aggregation state on the toxicity of different amphotericin B preparations

    International Journal of Pharmaceutics, Vol. 361, Núm. 1-2, pp. 64-69

  3. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B

    International Journal of Antimicrobial Agents, Vol. 32, Núm. 1, pp. 55-61

  4. HPLC assay for determination of amphotericin B in biological samples

    Biomedical Chromatography, Vol. 22, Núm. 4, pp. 402-407

  5. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 5, pp. 1125-1131

1993

  1. Equipos industriales de obtención de pelets y control de calidad de los mismos

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 1, pp. 33-37

1992

  1. Los Pelets como nuevo sistema de administración oral de medicamentos: conceptos generales

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 6, pp. 61-66